Avid Bioservices, Inc. (CDMO)
Avid Bioservices, Inc. (CDMO)
$5.61 USD
Updated Sep 13 6:55pm
Add CDMO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 216 in Medical - Pharmaceuticals
See all “A” rated Strong Buy stocks
CDMO Stock Chart More Charts
CDMO Price/Volume Stats
| Current price | $5.61 |
| Prev. close | $5.40 |
| Day low | $5.50 |
| Day high | $5.68 |
| 50-day MA | $6.35 |
| 200-day MA | $4.78 |
| 52-week high | $7.37 |
| 52-week low | $3.37 |
| Volume | 459,700 |
| Avg. volume | 331,169 |
| Dividend yield | N/A |
| Market Cap | 315.50M |
Avid Bioservices, Inc. (CDMO) Company Bio
Avid Bioservices, Inc., formerly Peregrine Pharmaceuticals, researches and develops monoclonal antibodies for the treatment of cancer in the United States. Its lead immunotherapy candidate includes bavituximab, a monoclonal antibody that targets and binds to phosphatidylserine. The company was founded in 1981 and is based in Tustin, California.
Top Stories View All
101 Fresh Upgrades to Start the Week
2900 or 3100: Which Comes Next?
Best & Worst Performing Stock Industries for September 13, 2019
Best & Worst Performing Small Cap Stocks for September 13, 2019
Best & Worst Performing Large Cap Stocks for September 13, 2019
View All Top Stories
Loading social stream, please wait...